Skip to Content for (none) Menu for (none) About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image
March Tuesday, Mar 16, 2010
Genentech Submits Supplemental Biologics License Application for ACTEMRA (tocilizumab) for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis

Thursday, Mar 11, 2010
Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer

February Wednesday, Feb 24, 2010
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer

Monday, Feb 22, 2010
Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint

Thursday, Feb 18, 2010
FDA Approves Rituxan Plus Chemotherapy for the Most Common Type of Adult Leukemia

January Friday, Jan 15, 2010
FDA Extends Review Period for Tarceva Application for First-line Maintenance Use in Advanced Non-small Cell Lung Cancer

Friday, Jan 08, 2010
FDA Approves ACTEMRA® (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis

See the Archives See the Archives
 
Search Releases

Begin Date:


End Date:


Category:
Keyword: